Financials

  • Market Capitalization 3.5 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
51.34
Relación precio/flujo de caja
6.56

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1513
TNGX
Tango Therapeutics, Inc. - Common Stock
22.06 USD-8.73%+3.13%-8.01%+163.56%3.72 B USD
1517
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
10.87 USD-3.72%+0.65%-11.12%+72.27%3.68 B USD
1578
XENE
Xenon Pharmaceuticals Inc. - Common Shares
34.64 USD-3.27%-3.86%-41.64%-15.08%3.35 B USD
1582
IDYA
IDEAYA Biosciences, Inc. - Common Stock
34.55 USD-4.19%-5.68%-10.26%+6.05%3.33 B USD

Noticias